RuncheyResearch

Archived research. Equity forecasting is part of the Runchey Research archive (methodology era 1) and is no longer actively updated. Everything remains published at its original URL. Browse the archive

Back to Forecasting

CC Forecast Markets

The Chemours Company

7
Active Markets
26%
Avg Probability
Price Above Value
Apr 22, 2026

Our prediction ensemble identifies elevated risk at current levels.

7 markets analyzedConfidence: MEDIUM
Read Full Thesis

All Markets

7 markets

Will the North Carolina PFAS bellwether trial return an adverse verdict against Chemours by 2026-09-30?

Active
32%
Likely No
88% agreement
Sep 30, 2026
IG: 0.80

Will Chemours disclose material findings from the audit committee internal review by year-end 2026?

Active
18%
Likely No
85% agreement
Dec 31, 2026
IG: 0.80

Will Chemours TT segment Adjusted EBITDA margin print below 5% in any quarter of 2026?

Active
38%
Likely No
90% agreement
Mar 15, 2027
IG: 0.64

Will the EU PFAS final rule be published without a fluoropolymer/polymer-of-low-concern carve-out by 2026-12-31?

Active
15%
Likely No
88% agreement
Dec 31, 2026
IG: 0.64

Will Chemours disclose DuPont MOU remaining capacity below $500M (its $2B share) by 2026-12-31?

Active
28%
Likely No
87% agreement
Dec 31, 2026
IG: 0.60

Will the civil RICO motion to dismiss against Chemours be granted (fully or in material part) by 2026-12-31?

Active
32%
Likely No
82% agreement
Dec 31, 2026
IG: 0.60

Will TSS segment trailing-twelve-months Adjusted EBITDA fall below $600M as disclosed by the Q3 2026 10-Q?

Active
22%
Likely No
90% agreement
Nov 30, 2026
IG: 0.48

Resolution Timeline

Sep 30, 2026
Will the North Carolina PFAS bellwether trial return an adverse verdict against Chemours by 2026-09-30?
Prediction: 32%
Nov 30, 2026
Will TSS segment trailing-twelve-months Adjusted EBITDA fall below $600M as disclosed by the Q3 2026 10-Q?
Prediction: 22%
Dec 31, 2026
Will Chemours disclose material findings from the audit committee internal review by year-end 2026?
Prediction: 18%
Dec 31, 2026
Will the EU PFAS final rule be published without a fluoropolymer/polymer-of-low-concern carve-out by 2026-12-31?
Prediction: 15%
Dec 31, 2026
Will Chemours disclose DuPont MOU remaining capacity below $500M (its $2B share) by 2026-12-31?
Prediction: 28%
Dec 31, 2026
Will the civil RICO motion to dismiss against Chemours be granted (fully or in material part) by 2026-12-31?
Prediction: 32%
Mar 15, 2027
Will Chemours TT segment Adjusted EBITDA margin print below 5% in any quarter of 2026?
Prediction: 38%